Dr. Birka Lehmann studied Medicines at the Free University Berlin and trained at the Kinderklinik Norderney. Her working experience includes 9 years preclinical assessment in the division ‘Pharmacology and Toxicology’ of the Federal Institute for Drugs and Medical Devices (BfArM) and she served as head of unit ‘Decentralised Procedure’ (1996-2002) and as deputy head of EU Division (2000-2002). She joined the European Commission, Directorate-General Enterprise and Industry (2002 – 2006) as seconded national expert in the unit ‘Pharmaceuticals’ responsible for Directive 2001/20/EC follow-up and implementing measures and centralised and decentralised marketing authorisations.
From 9/2006 – 10/2011 she was head of Licensing Division 3 and is now head of EU & International Affairs at BfArM. Since July 2007 she is alternate member at the PDCO for Germany and chairperson of the BfArM multidisciplinary working group on Nanomedicin.